Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriko Fujita is active.

Publication


Featured researches published by Noriko Fujita.


Alimentary Pharmacology & Therapeutics | 2000

A new mechanism for anti‐inflammatory actions of proton pump inhibitors – inhibitory effects on neutrophil–endothelial cell interactions

Norimasa Yoshida; Toshikazu Yoshikawa; Yukiko Tanaka; Noriko Fujita; Kyoichi Kassai; Yuji Naito; Motoharu Kondo

Background: Neutrophil–endothelial cell interactions mediated by adhesion molecules may be involved in gastric mucosal inflammation associated with Helicobacter pylori or nonsteroidal anti‐inflammatory drugs.


Inflammation Research | 2006

Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors.

Osamu Handa; Norimasa Yoshida; Noriko Fujita; Yukiko Tanaka; Miho Ueda; Tomohisa Takagi; Satoshi Kokura; Yuji Naito; Takeshi Okanoue; Toshikazu Yoshikawa

Abstract.ObjectiveInterleukin (IL)-8 has been reported to participate in neutrophil infiltration in Helicobacter pylori (H. pylori)-induced gastritis in humans. In this study, we investigated the anti-inflammatory actions beyond the suppression of acid secretion by proton pump inhibitors (PPI), such as omeprazole and lansoprazole, on IL-8 production by gastric epithelial cells (MKN45) and human umbilical vein endothelial cells (HUVEC) and on the transendothelial migration of polymorphonuclear neutrophils (PMN).Materials and methodsMKN45 and HUVEC were stimulated with H. pylori water extract (HPE) and IL-1β, respectively, and nuclear factor kappa B (NFκB) activation and subsequent IL-8 production was assessed in the absence or presence of PPI. We also assessed the effect of PPI on IL-8-induced PMN transendothelial migration and on the alteration of cytoplasmic calcium concentration in formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated PMN.ResultsHPE and IL-1β induced a significant increase in IL-8 production by MKN45 and HUVEC, respectively, along with NFκB activation, which was significantly inhibited by PPI. PPI also inhibited the IL-8-induced transendothelial migration of PMN and the fMLP-induced cytosolic calcium increase in PMN.ConclusionsPPI attenuate PMN-dependent gastric mucosal inflammation partly by interfering with NFκB activation in vascular endothelial cells and gastric epithelial cells, and partly by modulating the calcium concentration of PMN.


European Journal of Pharmacology | 2002

α-Tocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation

Manabu Uemura; Hiroki Manabe; Norimasa Yoshida; Noriko Fujita; Jun Ochiai; Naohisa Matsumoto; Tomohisa Takagi; Yuji Naito; Toshikazu Yoshikawa

Alpha-tocopherol has been reported to exert an anti-atherogenesis effect. We attempted to clarify the effect of alpha-tocopherol-both as an antioxidant and as a nonantioxidant--on apoptosis induced by oxidized low-density lipoprotein (LDL) or oxysterols. Oxidized LDL and oxysterols induced necrosis and/or apoptosis of vascular endothelial cells. The induction of apoptosis was associated with increased caspase-3 activity and the generation of intracellular reactive oxygen species, both the effects of which were attenuated by alpha-tocopherol. Apoptosis was also decreased by beta-tocopherol or intracellular radical scavengers, but these suppressive effects were less than those of alpha-tocopherol. Neither beta-tocopherol nor the scavengers had pronounced effect on caspase-3 activity, but each of them decreased the generation of reactive oxygen species to the same extent as alpha-tocopherol. Our study suggests that alpha-Toc protects against apoptosis not only by scavenging reactive oxygen species, but also by inhibiting caspase activity, which means that its activity may exceed that of a mere antioxidant.


Shock | 2003

An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity.

Naoyuki Matsumoto; Hiroki Manabe; Jun Ochiai; Noriko Fujita; Tomohisa Takagi; Manabu Uemura; Yuji Naito; Norimasa Yoshida; Shigenori Oka; Toshikazu Yoshikawa

The protective effects and roles of AT1-receptor antagonists (AT1-RA) or angiotensin-converting enzyme inhibitors (ACEI) on vascular endothelial cell (EC) injury during hypoxia are not entirely known. Therefore, we investigated these effects and mechanisms in human aortic (HA) EC. DNA fragmentation, Lactate dehydrogenase (LDH) release, and caspase-3 activity were measured in cultured HAEC after exposure to hypoxia in the presence or absence of an AT1-RA (candesartan, CS) and/or an ACEI (temocaprilat, TC). Next, we investigated endothelial cell nitric oxide synthase (ecNOS) and inducible (i) NOS to determine the role of the bradykinin(BK)-NO pathway in the protective effect on ACEI and AT1-RA in the setting of hypoxia-induced apoptosis. Exposure to hypoxia increased DNA fragmentation in HAEC associated with the activation of caspase-3, but did not affect LDH release. In addition, hypoxia induced ecNOS mRNA but not mRNA iNOS. CS and/or TC reduced apoptosis induced by hypoxia in a dose-dependent manner, and significantly increased BK and ecNOS expression. This effect was attenuated by the kinin B2 receptor antagonist, HOE 140, and the NOS inhibitor, N-nitro-l-arginine methylester (L-NMMA). Hypoxia activates the pathway leading to apoptosis by enhancing caspase-3 activity. Both CS and TC can ameliorate hypoxia-induced apoptosis in HAEC through inhibiting caspase-3 activation by enhancing ecNOS activity, via the accumulation of BK.


Alimentary Pharmacology & Therapeutics | 2000

Protective role of intracellular glutathione against nitric oxide‐induced necrosis in rat gastric mucosal cells

Yuji Naito; Toshikazu Yoshikawa; Yoshio Boku; Takaaki Fujii; Yasuharu Masui; Yukiko Tanaka; Noriko Fujita; Norimasa Yoshida; Motoharu Kondo

Background: Nitric oxide synthase activity is increased in the stomach in association with Helicobacter pylori infection and portal hypertension, but the mechanism by which nitric oxide contributes to mucosal damage remains unclear.


Biofactors | 2000

Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injury

Noriko Fujita; Hiroki Manabe; Norimasa Yoshida; Naohito Matsumoto; Jun Ochiai; Yasuharu Masui; Manabu Uemura; Yuji Naito; Toshikazu Yoshikawa


Journal of Clinical Biochemistry and Nutrition | 2002

An Angiotensin-Converting Enzyme Inhibitor Suppresses the Expression of Vascular Cell Adhesion Molecule-1 and Production of Cytokines Induced in Activated Endothelial Cells

Jun Ochiai; Hiroki Manabe; Norimasa Yoshida; Tomohisa Takagi; Naoyuki Matsumoto; Noriko Fujita; Manabu Uemura; Yuji Naito; Toshikazu Yoshikawa


Gastroenterology | 2009

M1922 Prediction of Two Types of Unresponsive Gastroesophageal Reflux Disease to Proton Pump Inhibitor Therapy: Examination of Pre Treatment Factors

Nobuaki Yagi; Sotaro Fujimoto; Naoya Tomatsuri; Takashi Ando; Yuji Naito; Toshikazu Yoshikawa; Hirokazu Oyamada; Kiichi Matsuyama; Jun Ochiai; Takama Maekawa; Keiichi Oki; Hirotomo Ootsuka; Takashi Tomii; Noriko Fujita


Journal of Clinical Biochemistry and Nutrition | 2001

Inhibition of Angiotensin-Converting Enzyme Protects Endothelial Cells against Oxysterol-Induced Apoptosis

Noriko Fujita; Hiroki Manabe; Norimasa Yoshida; Naohito Matsumoto; Jun Ochiai; Yasuharu Masui; Manabu Uemura; Yuji Naito; Toshikazu Yoshikawa


Gastroenterology | 2001

Inhibitory effects of proton pump inhibitors on IL-8 production and neutrophil migration

Osamu Handa; Norimasa Yoshida; Tomohisa Takagi; Takeshi Ishikawa; Naoyuki Matsumoto; Yukiko Tanaka; Noriko Fujita; Yuji Naito; Toshikazu Yoshikawa

Collaboration


Dive into the Noriko Fujita's collaboration.

Top Co-Authors

Avatar

Toshikazu Yoshikawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yuji Naito

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Norimasa Yoshida

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Tomohisa Takagi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hiroki Manabe

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Manabu Uemura

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yukiko Tanaka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Jun Ochiai

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Motoharu Kondo

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Naoyuki Matsumoto

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge